• Explore /
  • Poster
  • / Survival benefit of maintenance therapy in AML patients after complete remission in northeast Iran oncology centers with limited access to oral azacitidine.

Survival benefit of maintenance therapy in AML patients after complete remission in northeast Iran oncology centers with limited access to oral azacitidine.

Abstract Video & Slides Poster

Authors

null

Somayeh Sadat Shariatmaghani

Mashhad University of Medical Science, Mashhad, Iran (Islamic Republic of)

Somayeh Sadat Shariatmaghani , Mohammad Moeini Nodeh , Maryam Emadzadeh , Abollghasem Allahyari , Hossein Rahimi , Zahra Mozaheb , Mohsen Seddigh Shamsi , Sajad ataei Azimi , Alireza Bary , Tahereh Mohaddes , Eisa Nazar , Farnoush Davoudi , Zahra Rezaei Borojerdi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session A

Track

Breast Cancer,Central Nervous System Tumors,Developmental Therapeutics,Genitourinary Cancer,Hematologic Malignancies,Thoracic Cancers,Other Malignancies or Topics

Sub Track

Other Therapeutic Interventions

Citation

JCO Global Oncology 9, 2023 (suppl 1; abstr 123)

DOI

10.1200/GO.2023.9.Supplement_1.123

Abstract #

123

Poster Bd #

F6

Abstract Disclosures

Similar Posters

First Author: Farhad Ravandi

First Author: Gail J. Roboz

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.

Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.

First Author: Michele Reni

First Author: Amer Methqal Zeidan